Study in the relationship between risk factors and pattern of recurrence after complete surgery for adenocarcinoma of the uterine cervix

Acta Obstetrica et Gynaecologica Japonica

Volumn 49, Issue 5, 1997, Pages 249-255

  Utsugi, Kuniko ^a   Shimizu, Yoshio ^a   Umezawa, Satoshi ^a   Akiyama, Futoshi ^b   Yamauchi, Kazuhiro ^a   Hasumi, Katsuhiko ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b CANCER INSTITUTE   (Japan)

Author keywords

Adjutant therapy; Cervical adenocarcimona; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; RECURRENCE RISK; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA;

EID: 0030926201     PISSN: 03009165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delelos L. Adenocarcinoma of the uterine cervix. Prognosis and pattern of failure in 367 cases. Cancer 1990 ; 65 : 2507-2514
2. Miller BE, Flax SD, Arheart K, Photopulos G. The presentation of adenocarcinoma of the uterine cervix. Cancer 1993 ; 72 : 1281-1285
3. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991 ; 77 : 912-917
4. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 1995 ; 59 : 38 -44
5. Kilgore LC, Soong SJ, Gore H, Shinglelon HM, Halch KD, Partridge EE. Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol 1988 ; 31 : 137-148
6. McLellan R, Dillon MB, Woodruff JD, Heatley GJ, Fields AL, Rosenshein NB. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery. Gynecol Oncol 1994 ; 52 : 253-259
7. Hopkins MP, Schmidt RW, Roberts JA, Morley GW. The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet Gynecol 1988 ; 72 : 915-921
8. Greer BE, Figge DC, Tamimi HK, Cain JM. Stage IB adenocarcinoma of the cervix treated by radical hysterectomy and pelvic lymph node dissection. Am J Obstet Gynecol 1989 ; 160 : 1509-1514
9. Mann WJ, Chumas J, Amalfitano T, Westermann C, Patsner B. Ovarian metastasis from stage IB adenocarcinoma of the cervix. Cancer 1987 ; 60 : 1123-1126
10. Goodman HM, Bultlar CA, Niloff JM, Welch WR, Marck A, Feuer EJ, Lahman EA, Jenison EL, Knapp RC. Adenocarcinoma of the uterine cervix : Prognostic factors and patterns of recurrence. Gynecol Oncol 1989 ; 33 : 241-247
11. Matthew CM, Burke TW, Tornos C, Eifel PJ. Atkinson EN, Stringer CA, Morris M, Silva EG. Stage I cervical adenocarcinoma : Prognostic Evaluation of surgically treated patients. Gynecol Oncol 1993 ; 49 : 19-23
12. Korhonen MO. Adenocarcinoma of the uterine cervix. Cancer 1984 ; 53 : 1760-1763
13. Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Lewis JL Jr. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986 ; 57 : 1584-1593
14. Eifel PJ, Burke TW, Delelos L, Wharton JT, Oswald MJ. Early stage I adenocarcinoma of the uterine cervix : Treatment results in patients with tumors≦4cm in diameter. Gynecol Oncol 1991 ; 41 : 199-205
15. Berek JS, Hacker NF, Fu YS, Sokale J, Leuchter RC, Lagasse LD. Adenocarcinoma of the uterine cervix : Histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 1985 ; 65 : 46-52
16. Thigpen JT, Blessing JA, Fowler WC Jr, Hatch K. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix : A gynecologic oncology group study. Cancer Treat Reports 1986 ; 70 : 1097-1100
17. Bates R, Deppe G, Malone JM Jr, Budev H, Christensen CW, Malviya VK. Combination chemotherapy for advanced adenocarcinoma of the cervix. Cancer 1991 ; 68 : 747-750
18. Kavanagh JJ, Gershenson D, Copeland L, Roberts WS. Combination chemotheray for metastatic or recurrent adenocarcinoma of the cervix. J Clin Oncol 1987 ; 5 : 1621-1623
19. Slayton RE, Blessing JA, Homesley HD. Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix : A Gynecologic Oncology Group Study. Cancer Treat Reports 1984 ; 68 : 1513-1514
20. Kavanagh JJ, Copeland L, Gershenson D, Roberts W. Continuous-infusion vinblastine for treatment of refractory adenocarcinoma of the cervix. Cancer Treat Reports 1987 ; 71 : 547-548
21. Slayton RE, Blessing JA, Rettenmaier M, Ball H. A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group Study. Invest New Drugs 1989 ; 7 : 337-340
22. Homesley HD, Blessing JA, Berman M. ICRF-159 (Razoxane) in patients with advanced non-squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study. Am J Clin Oncol (CCT) 1986 ; 9 : 325-326
23. Stehman FB, Blessing JA, Homesley HD, Currie JL, Yordan EL. Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group Study. Invest New Drugs 1984 ; 2 : 331-333